Drug Safety

Does the FDA adequately protect the public?

Introduction

The sudden withdrawal of the blockbuster arthritis drug Vioxx and warnings about similar medications — including heightened suicide risks from antidepressants — have focused unprecedented negative attention on the Food and Drug Administration (FDA). Two congressional committees, the Government Accountability Office and the Institute of Medicine have begun looking at the agency's performance, and several lawmakers are proposing overhauling the way the FDA operates. Critics say the agency suffers from deep-seated flaws, including conflicts of interest, an inattention to safety issues and a lack of enforcement authority. An FDA medical reviewer testified recently the agency's close relationship with the drug industry and its tendency to rush drugs to market has left the country “virtually defenseless.” But FDA and drug-industry officials say the U.S. still enjoys ...

locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles